KR20010000706A - 새로운 기능성 소금의 제조 방법과 용도의 개발 - Google Patents
새로운 기능성 소금의 제조 방법과 용도의 개발 Download PDFInfo
- Publication number
- KR20010000706A KR20010000706A KR1020000060499A KR20000060499A KR20010000706A KR 20010000706 A KR20010000706 A KR 20010000706A KR 1020000060499 A KR1020000060499 A KR 1020000060499A KR 20000060499 A KR20000060499 A KR 20000060499A KR 20010000706 A KR20010000706 A KR 20010000706A
- Authority
- KR
- South Korea
- Prior art keywords
- salt
- chitosan
- solution
- skin
- blood pressure
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 121
- 238000004519 manufacturing process Methods 0.000 title abstract description 7
- 238000011161 development Methods 0.000 title abstract description 4
- 230000000975 bioactive effect Effects 0.000 title 1
- 229920001661 Chitosan Polymers 0.000 claims abstract description 100
- 239000012266 salt solution Substances 0.000 claims abstract description 10
- 235000009827 Prunus armeniaca Nutrition 0.000 claims description 11
- 244000018633 Prunus armeniaca Species 0.000 claims description 11
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 11
- 241000218671 Ephedra Species 0.000 claims description 8
- 210000004207 dermis Anatomy 0.000 claims description 8
- 241001474374 Blennius Species 0.000 claims description 7
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 7
- 239000000606 toothpaste Substances 0.000 claims description 7
- 229940034610 toothpaste Drugs 0.000 claims description 7
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 6
- 244000246386 Mentha pulegium Species 0.000 claims description 6
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 6
- 235000001050 hortel pimenta Nutrition 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 235000010755 mineral Nutrition 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 239000011573 trace mineral Substances 0.000 claims description 2
- 235000013619 trace mineral Nutrition 0.000 claims description 2
- 230000036772 blood pressure Effects 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 7
- 239000000243 solution Substances 0.000 abstract description 4
- 238000003756 stirring Methods 0.000 abstract description 4
- 241000238366 Cephalopoda Species 0.000 abstract description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract description 2
- 241000238557 Decapoda Species 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 239000012047 saturated solution Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 241000206607 Porphyra umbilicalis Species 0.000 description 13
- 235000011194 food seasoning agent Nutrition 0.000 description 12
- 230000000845 anti-microbial effect Effects 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- 230000035882 stress Effects 0.000 description 8
- 239000000460 chlorine Substances 0.000 description 7
- 206010020772 Hypertension Diseases 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 241000194019 Streptococcus mutans Species 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical group C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 5
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 5
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 241000675108 Citrus tangerina Species 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000001631 hypertensive effect Effects 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 208000000112 Myalgia Diseases 0.000 description 3
- 238000003287 bathing Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 208000013465 muscle pain Diseases 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 102000005862 Angiotensin II Human genes 0.000 description 2
- 101800000733 Angiotensin-2 Proteins 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229950006323 angiotensin ii Drugs 0.000 description 2
- 230000004531 blood pressure lowering effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 239000010871 livestock manure Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 101800000734 Angiotensin-1 Proteins 0.000 description 1
- 102400000344 Angiotensin-1 Human genes 0.000 description 1
- KLYCPFXDDDMZNQ-UHFFFAOYSA-N Benzyne Chemical compound C1=CC#CC=C1 KLYCPFXDDDMZNQ-UHFFFAOYSA-N 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 102000002397 Kinins Human genes 0.000 description 1
- 108010093008 Kinins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N aldehydo-N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- ORWYRWWVDCYOMK-HBZPZAIKSA-N angiotensin I Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 ORWYRWWVDCYOMK-HBZPZAIKSA-N 0.000 description 1
- 238000000222 aromatherapy Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000035597 cooling sensation Effects 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000001916 dieting Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 239000001967 plate count agar Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- -1 salt chlorine ions Chemical class 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/40—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by drying or kilning; Subsequent reconstitution
- A23L3/46—Spray-drying
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/51—Polysaccharide
- A23V2250/511—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/50—Concentrating, enriching or enhancing in functional factors
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (5)
- ㄱ. 소금 용액에 키토산이 고형물 기준으로 0.1 ∼ 5 %를 함유하도록 용해시킨 다음 건조하여 재결정시킨 키토산을 함유한 소금.
- ㄴ. ㄱ항에 따른 키토산을 함유한 소금을 유효성분으로 하는 치약.
- ㄷ. ㄱ항에 따른 키토산을 함유한 소금을 유효성분으로 하는 조미김 제조용 소금.
- ㄹ. ㄱ항에 따른 키토산을 함유한 소금과 박하, 살구씨, 진피, 마황 등을 포함하는 목욕용 소금.
- ㅁ. ㄱ항에 따른 키토산을 함유한 소금을 제조할 때 수용액 상태에서 비타민류 및 미량요소 미네랄을 첨가하여 재결정시킨 기능성 소금.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0060499A KR100466579B1 (ko) | 2000-10-06 | 2000-10-06 | 키토산을 이용한 기능성 소금의 제조 방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0060499A KR100466579B1 (ko) | 2000-10-06 | 2000-10-06 | 키토산을 이용한 기능성 소금의 제조 방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010000706A true KR20010000706A (ko) | 2001-01-05 |
KR100466579B1 KR100466579B1 (ko) | 2005-01-15 |
Family
ID=19693502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2000-0060499A KR100466579B1 (ko) | 2000-10-06 | 2000-10-06 | 키토산을 이용한 기능성 소금의 제조 방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100466579B1 (ko) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020028764A (ko) * | 2001-07-25 | 2002-04-17 | 송병식 | 키토산과 천연소금을 함유한 잇몸보호를 위한 치약조성물 |
KR20020028765A (ko) * | 2001-07-25 | 2002-04-17 | 송병식 | 생약추출물과 키토산을 함유한 치주 질환 예방을 위한치약조성물 |
KR20030016712A (ko) * | 2001-08-21 | 2003-03-03 | 권오역 | 멘톨이 첨가된 미용염 및 그 제조방법 |
KR100383389B1 (ko) * | 2000-12-30 | 2003-05-12 | (주)미화 | 미네랄-글루콘산염을 함유하는 기능성 소금의 제조방법 |
KR20030087468A (ko) * | 2002-05-10 | 2003-11-14 | 정만종 | 키토 올리고당을 함유하는 건강 맛소금의 제조방법 및 그방법에 의해 제조된 건강 맛소금 |
WO2004100681A1 (en) * | 2003-05-19 | 2004-11-25 | Gun Sik Cho | Method for producing a chitosan containing salt having a function of lowering blood pressure |
KR100743970B1 (ko) * | 2006-03-10 | 2007-07-30 | 김옥순 | 저염도 기능성 칼라소금. |
US8435555B2 (en) | 2008-05-01 | 2013-05-07 | Eminate Limited | Salt product |
US9808030B2 (en) | 2011-02-11 | 2017-11-07 | Grain Processing Corporation | Salt composition |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101039784B1 (ko) * | 2008-04-30 | 2011-06-09 | 조건식 | 키토산 천일염의 제조 방법 |
KR101223809B1 (ko) | 2010-09-08 | 2013-01-17 | 문지은 | 기능성 자염 제조방법 |
US20170238591A1 (en) * | 2014-10-14 | 2017-08-24 | Borja Blázquez Ancin | Process for the preparation of a powdered flavoring based on macruran decapod crustaceans, the flavoring product obtained with it and cooking salt flavored with said product |
KR101753350B1 (ko) | 2015-08-25 | 2017-07-19 | 태현식품 | 게 또는 새우 발효물을 포함하는 기능성 천일염 및 그의 제조 방법 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3159610B2 (ja) * | 1994-08-23 | 2001-04-23 | 株式会社キングジム | 印画作成装置 |
-
2000
- 2000-10-06 KR KR10-2000-0060499A patent/KR100466579B1/ko active IP Right Grant
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100383389B1 (ko) * | 2000-12-30 | 2003-05-12 | (주)미화 | 미네랄-글루콘산염을 함유하는 기능성 소금의 제조방법 |
KR20020028764A (ko) * | 2001-07-25 | 2002-04-17 | 송병식 | 키토산과 천연소금을 함유한 잇몸보호를 위한 치약조성물 |
KR20020028765A (ko) * | 2001-07-25 | 2002-04-17 | 송병식 | 생약추출물과 키토산을 함유한 치주 질환 예방을 위한치약조성물 |
KR20030016712A (ko) * | 2001-08-21 | 2003-03-03 | 권오역 | 멘톨이 첨가된 미용염 및 그 제조방법 |
KR20030087468A (ko) * | 2002-05-10 | 2003-11-14 | 정만종 | 키토 올리고당을 함유하는 건강 맛소금의 제조방법 및 그방법에 의해 제조된 건강 맛소금 |
WO2004100681A1 (en) * | 2003-05-19 | 2004-11-25 | Gun Sik Cho | Method for producing a chitosan containing salt having a function of lowering blood pressure |
US7335766B2 (en) | 2003-05-19 | 2008-02-26 | Gun Sik Cho | Method for producing a chitosan containing salt having a function of lowering blood pressure |
KR100743970B1 (ko) * | 2006-03-10 | 2007-07-30 | 김옥순 | 저염도 기능성 칼라소금. |
US8435555B2 (en) | 2008-05-01 | 2013-05-07 | Eminate Limited | Salt product |
US9491961B2 (en) | 2008-05-01 | 2016-11-15 | Eminate Limited | Salt product |
US9808030B2 (en) | 2011-02-11 | 2017-11-07 | Grain Processing Corporation | Salt composition |
Also Published As
Publication number | Publication date |
---|---|
KR100466579B1 (ko) | 2005-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002241299A (ja) | メイラード反応修復剤 | |
JPH1036283A (ja) | 線維芽細胞増殖促進剤 | |
KR100466579B1 (ko) | 키토산을 이용한 기능성 소금의 제조 방법 | |
JPH11106336A (ja) | メイラード反応阻害剤 | |
CN102988231A (zh) | 一种女性护理液及其制备方法 | |
CN106265370A (zh) | 一种有效防止病理性脱发的洗发液及其制备方法 | |
CN110787114A (zh) | 一种去屑止痒控油的泡沫洗发液及其制备方法 | |
CN107432847B (zh) | 清洁与清凉皮肤的组合物和化妆品 | |
CN108379411A (zh) | 改善睡眠质量的中药泡浴速溶颗粒及制备与使用方法 | |
KR20110013685A (ko) | 해양심층수, 발효흑생강 추출물 및 대추농축액을 주성분으로 하는 기능성 음료조성물 | |
KR100962534B1 (ko) | 허브추출물들을 포함하는 비누 조성물 | |
CN109077940A (zh) | 一种电解水制备的美容面膜及其制备方法 | |
JP3563021B2 (ja) | 化粧用パックの製造方法 | |
CN107982111A (zh) | 一种含有桧木芬多精爽肤水及其制备方法 | |
JP2000143524A (ja) | アマランサス抽出物含有抗炎症剤 | |
JP2002316937A (ja) | 植物抽出物含有抗アレルギー剤 | |
KR20020090177A (ko) | 녹차, 다시마, 징꼬, 마늘 성분이 함유된 저염도 기능성소금의 제조방법 | |
CN106265393A (zh) | 一种黑头抓取面膜 | |
CN108186440A (zh) | 可抗菌护肤的中药植物沐浴露及其制备方法和用途 | |
CN105169463B (zh) | 一种阳离子婴儿医用敷料及其制备方法 | |
KR101969983B1 (ko) | 토판염을 함유한 탈모개선 샴푸 조성물 및 이의 제조방법 | |
CN109646359B (zh) | 一种具有清洁净化和美容养颜功效的玫瑰木耳泥膜膏及其制备方法 | |
JP4079908B2 (ja) | 化粧用パック | |
JP5414137B2 (ja) | ヒアルロニダーゼ活性阻害剤 | |
JP4169814B2 (ja) | リュウゼツラン又はサイザル抽出物含有皮膚外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
B601 | Maintenance of original decision after re-examination before a trial | ||
J301 | Trial decision |
Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20030723 Effective date: 20040825 |
|
S901 | Examination by remand of revocation | ||
E902 | Notification of reason for refusal | ||
GRNO | Decision to grant (after opposition) | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130107 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20140106 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20150106 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20160106 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20161226 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20180207 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20190107 Year of fee payment: 15 |